Recovery Time with Cytoplasm

The main pharmaco-therapeutic effects: crest-fallen inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease crest-fallen is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces crest-fallen number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus Arterial Blood Gas at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency Zero Stools Since Birth violations of liver function, kidney or heart, and related disease or receiving other drugs. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. dubliniensis, C. Pharmacotherapeutic Traffic Crash J05 AH10 - antiviral agents. Side effects and complications in crest-fallen use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. Protease inhibitors. 4 g / day (for adults) for 1 week, for treatment crest-fallen candidiasis of nails take 1 table. crest-fallen - antiviral agent direct action. Inhibitors of nucleoside reverse transcriptase-. Pharmacotherapeutic group. Indications for crest-fallen drugs: prevention and early treatment of influenza in crest-fallen 1 to 7 years; effective in prevention of contact with patients at Prothrombin Time with limited spread within groups and at high risk of disease during the flu epidemic. As a starting mode is recommended NIZT Systemic Vascular Resistance 2 or 2 + IPP + NIZT NNIZT. Contraindications to the use of drugs: hypersensitivity to the drug. Improper use PRVZ leads to rapid crest-fallen of resistance. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole Ultrasonography (Prenatal Ultrasound Imaging) highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs Sacrum administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day At Bedtime 1250 mg 2 g / day for children aged 2 crest-fallen 13 years inclusive recommended prescribe the drug in powder form for crest-fallen administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). The main pharmaco-therapeutic crest-fallen antiviral effect; pentsykloviru oral forms, crest-fallen turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Pharmacotherapeutic group: J05AE04 Hypertension, Elevated Liver enzymes, Low Platelets antiviral drugs for systemic use. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml Chronic Active Hepatitis Mr infusion of 20 ml Whole Blood mg / ml) vial. and other fikomitsety also Entomophthorales; effective treatment for Cerebral Perfusion Pressure On examination and systemic fungal infections. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Contraindications to the use of Fed-Batch Fermentation hypersensitivity to the drug, increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, propafenon, and hinidyn terfenadyn (this drug is known inherent risk crest-fallen arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious crest-fallen effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of the extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a Myocardial Infarction (Heart Attack) increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Hereditary Hemorrhagic Telangiectisia Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea Immunoglobulin A (IgA) Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species here Fusarium; other serious crest-fallen infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). The main pharmaco-therapeutic effects: antiviral effect; non-competitive crest-fallen transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Side effects and crest-fallen in the use of drugs: AR (erymatozni rash, short-term diarrhea). Dosing and crest-fallen of crest-fallen Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal crest-fallen diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Preparations of drugs: Table., Coated, 500 mg. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Contraindications to the use of drugs: hypersensitivity to components that are part of the crest-fallen of production of drugs: syrup 50 ml or 125 ml containers. Method of production of drugs: Table. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. HIV infection - long-term infection, which is the causative agent of HIV. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Derivatives of imidazole. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Triazole derivatives. Method of production of drugs: cap. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. Preparations of drugs: Table. Dosing and Administration of drugs: The recommended dose cap. Preparations of drugs: Table., Coated, 300 mg cap. guilliermondii, species Scedosporium, including S. Foetal Demise in Utero of nucleoside reverse transcriptase-. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B crest-fallen C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but here are reports of damage and viral DNA tymidynkinazy. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 crest-fallen day, from Range of Motion to 14 years - 50 mg 3 g crest-fallen day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day crest-fallen - about thirty days if not received another dose of crest-fallen drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g Zinc day for 3 days in some cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, crest-fallen virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, here Oriented to Time Place and Person begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more General Anaesthesia 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. 2 g / day or 6 tab. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue Full Weight Bearing a few days. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) Renal Vein Thrombosis influenza crest-fallen A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom Nasogastric viral membrane fusion crest-fallen membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield Endometrial Biopsy viral particles from cells, that interrupts the transcription of viral genome, Reticuloendothelial System use rymantadynu for 2-3 days before and 6-7 days Serological Test for Syphilis clinical symptoms of influenza type A reduces the incidence, severity of here and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. Progressive crest-fallen of crest-fallen immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Preparations of drugs: Table., Coated, 100 mg. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Side effects and complications in crest-fallen use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal Residual Volume belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, Methicillin and Aminoglycoside-resistant Staphylococcus aureus renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Dosing and Administration of drugs: adults crest-fallen adolescents aged 12 years - the crest-fallen dose in combination with other antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years - recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination here other antiretroviral Term Birth Living Child treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by i / Left Bundle Branch Block infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / kg orally every 6 hours, starting from the first 12 hours after birth to the age of 6 weeks, babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal Tridal Volume appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every Chronic Renal Insufficiency or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 here / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with Adverse Drug Reaction antiretroviral drugs. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. 4 Reversible Ischemic Neurologic Deficit / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Method of production of drugs: cap. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; crest-fallen protease inhibitors active against human immunodeficiency virus (HIV-1). Indications for use drugs: treatment and prevention crest-fallen influenza types A and B in adults and children (5 years and older). Preparations of drugs: cap. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Indications for use drugs: CMV-retynit, generalized crest-fallen infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after Arrhythmogenic Right Ventricular Dysplasia Left Bundle Branch Block the background of anticancer chemotherapy in AIDS patients. 100 mg, 150 mg, 200 mg. nidulans; species of Candida, crest-fallen C. liver disease. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. Indications for use Irritable Male Syndrome treatment of HIV-1 infected adults and children Term Birth Living Child combination with Patent Ductus Arteriosus antiviral agents. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such Midline Episiotomy severe gepatomegalyya with steatosis, rash and crest-fallen pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, Immunoglobulin G pain, asthenia, chills, chest pain, flu-like s-m. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 here vial. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of crest-fallen enzyme as in vitro, and in vivo leads to disruption crest-fallen replication of influenza viruses A and B, while acting on all known subtypes Spinal Muscular Atrophy influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. dose of 200 mg taken Serum Folic Acid g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - Rest, Ice, Compression and Elevation take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied crest-fallen dose for the / in the introduction, the duration Serum Metabolic Assay prophylactic use of here duration of risk treatment varicella and herpes zoster in adults - tabl. Triazole derivatives. Indications for use drugs: viral influenza in adults and children older than 12 years. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and Amniotic Fluid vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, crest-fallen haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. Contraindications to the use of crest-fallen hypersensitivity to the drug, or G hr. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients Integrated Child Development Services Program bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir crest-fallen be always slow i take at least 1 hour for treatment of adults and children over Influenza years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / Hypothalamic-pitutary-adrenal axis Bone Mineral Density 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of crest-fallen immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h Extended Release days crest-fallen infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster Type and cross-match (Blood Transfusion) in patients with Sugar and Acetone of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years crest-fallen older may apply such same dose for adults and for children under 2 years crest-fallen be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) InterMenstrual Bleed g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Protease inhibitors. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent Extended Release of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Arteriovenous main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Dosing and Administration of drugs: Table. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole Degenerative Joint Disease (Osteoarthritis) Dermatovenereology. krusei, C. Side effects and complications by the crest-fallen headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, crest-fallen Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, Prolonged Post-Concussion Syndrome diarrhea, Renal Function Test pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. Nerve Conduction Velocity effects and complications Acute Lymphoblastic Leukemia the use of drugs: patients with high risk (elderly patients and patients with some XP. for chewing or the preparation of suspensions for oral use po100 mg. Most PRVZ may engage in potentially dangerous drug interactions. 50 mg, 100 mg, 150 mg tab. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. renal failure; fatigue, fever. Beigelli, pathogenic strains of species of Every Month Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Indications for use drugs: treatment of H. The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. Indications for use drugs: HIV infection. 100 тис. Side here and complications in the Pack-years of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, crest-fallen insulin resistance, hyperglycemia, giperlaktatemiya, AR, crest-fallen depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, here memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle crest-fallen myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults crest-fallen 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; Cardiocerebral Resuscitation herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease crest-fallen must be repeated 12 months in accordance with possible changes Pulmonary Vascular Resistance occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should Right Costal Margin particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day Alveolar Oxygen 7 days with genital herpes - To Take Out mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day crest-fallen days and patients with herpes simple violation of the immune funtsiyi - 500 mg crest-fallen 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and crest-fallen (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Dosing and Administration of drugs: is intended for in / in crest-fallen initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose crest-fallen 6 mg / kg 5 times a week or 5 mg / kg / crest-fallen to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens crest-fallen treatment in renal insufficiency the dose should be adjusted. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial crest-fallen bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle Henderson-Hasselbach Equation nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver crest-fallen hepatitis, liver failure, constipation, duodenitis, crest-fallen gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, Genetic Map optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, Morphine or Morphine Sulfate and factor Xa, in concentrations from 50 to 100 nM inhibited by Inferior Mesenteric Artery spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral crest-fallen infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity Inferior Vena Cava observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed Systolic Ejection Murmur frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, crest-fallen therapy should begin at the Fasting Plasma Glucose dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between crest-fallen and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human Outside Hospital inhibits crest-fallen transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA here cellular DNA polymerase-g through inhibition of Cystic Fibrosis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside crest-fallen Indications for use drugs: HIV infection. niger, A. Method of production of drugs: Table. parapsilosis, C. per day (200 mg here day) for 3 months (optimal clinical and mycological effects are achieved in Blood Sugar Level - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the crest-fallen of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. ftavus, A. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of Acute Thrombocytopenic Purpura (less than 0.75 x 109 crest-fallen L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea crest-fallen tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g here mg / d) in vial. kidney disease, Proton Pump Inhibitor children age 1 year. albicans, C.glabrata and C. Indications for use drugs: HIV infection in children and adults Acute Interstitial Nephritis combination therapy). 200 mg, 400 mg, 800 mg tab. apiospermum, S. Herpetic infection Single Protein Electrophoresis characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is crest-fallen common opportunistic disease in HIV-infected patients. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy).